Campbell & Co Investment Adviser’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Campbell & Co Investment Adviser's CNMD Position: Q1 2026 in Review
Campbell & Co Investment Adviser sold out of CONMED (CNMD) in Q1 2026, closing a stake of 52,522 shares — an estimated $2.13M sold.
Campbell & Co Investment Adviser first reported a position in CNMD in Q1 2018 and held it in 13 quarters. The position peaked at $2.17M in Q3 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Campbell & Co Investment Adviser reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Campbell & Co Investment Adviser sold 52,522 CONMED shares in Q1 2026, an estimated $2.13M.
- Campbell & Co Investment Adviser first reported a position in CONMED in Q1 2018 and held it in 13 quarters.
- Campbell & Co Investment Adviser's CONMED position peaked at $2.17M in Q3 2023.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.